Benitec Biopharma Statistics
Total Valuation
BNTC has a market cap or net worth of $81.50 million. The enterprise value is $72.28 million.
| Market Cap | 81.50M |
| Enterprise Value | 72.28M |
Important Dates
The last earnings date was Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BNTC has 9.37 million shares outstanding. The number of shares has increased by 58.95% in one year.
| Shares Outstanding | 9.37M |
| Shares Change (YoY) | +58.95% |
| Shares Change (QoQ) | +1.55% |
| Owned by Insiders (%) | 9.28% |
| Owned by Institutions (%) | 65.20% |
| Float | 6.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11,642.44 |
| Forward PS | n/a |
| PB Ratio | 10.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10,325.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.18 |
| Quick Ratio | 4.14 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -902.83 |
Financial Efficiency
Return on equity (ROE) is -175.40% and return on invested capital (ROIC) is -181.31%.
| Return on Equity (ROE) | -175.40% |
| Return on Assets (ROA) | -127.80% |
| Return on Capital (ROIC) | -181.31% |
| Revenue Per Employee | $438 |
| Profits Per Employee | -$1.36M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +113.34% in the last 52 weeks. The beta is 0.73, so BNTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +113.34% |
| 50-Day Moving Average | 7.92 |
| 200-Day Moving Average | 4.78 |
| Relative Strength Index (RSI) | 62.59 |
| Average Volume (20 Days) | 44,278 |
Short Selling Information
| Short Interest | 9,531 |
| Short Previous Month | 12,811 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, BNTC had revenue of $7,000 and -$21.69 million in losses. Loss per share was -$0.07.
| Revenue | 7,000 |
| Gross Profit | 4,667 |
| Operating Income | -14.33M |
| Pretax Income | -14.46M |
| Net Income | -21.69M |
| EBITDA | -14.22M |
| EBIT | -14.45M |
| Loss Per Share | -$0.07 |
Balance Sheet
The company has $9.45 million in cash and $236,008 in debt, giving a net cash position of $9.22 million or $0.98 per share.
| Cash & Cash Equivalents | 9.45M |
| Total Debt | 236,008 |
| Net Cash | 9.22M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 7.67M |
| Book Value Per Share | 0.82 |
| Working Capital | 7.29M |
Cash Flow
In the last 12 months, operating cash flow was -$13.47 million and capital expenditures -$119,337, giving a free cash flow of -$13.59 million.
| Operating Cash Flow | -13.47M |
| Capital Expenditures | -119,337 |
| Free Cash Flow | -13.59M |
| FCF Per Share | -$5.19 |
Margins
Gross margin is 66.67%, with operating and profit margins of -204,692.67% and -309,885.71%.
| Gross Margin | 66.67% |
| Operating Margin | -204,692.67% |
| Pretax Margin | -206,597.50% |
| Profit Margin | -309,885.71% |
| EBITDA Margin | -203,168.81% |
| EBIT Margin | -206,368.92% |
| FCF Margin | -194,139.93% |
Dividends & Yields
BNTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.95% |
| Shareholder Yield | -58.95% |
| Earnings Yield | -26.62% |
| FCF Yield | -16.68% |
Analyst Forecast
The average price target for BNTC is $23.00, which is 164.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.00 |
| Price Target Difference | 164.37% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 446.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.
| Last Split Date | Jul 26, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:17 |
Scores
BNTC has an Altman Z-Score of -0.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.19 |
| Piotroski F-Score | 3 |